首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Milan criteria.
【24h】

The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Milan criteria.

机译:肝细胞癌原发性肝切除术后肝移植的时机:特别参考复发模式和Milan标准。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Hepatic resection (HR) is commonly applied as first-line treatment of hepatocellular carcinoma (HCC) even in the era of liver transplantation (LT). METHODS: Outcomes and detailed recurrence pattern of 80 patients, who underwent curative HR for HCC were examined referring to Milan criteria. RESULTS: (I) After HR for HCCs exceeding Milan criteria (n=41), recurrence within the criteria was observed in 13 patients (group-A) and recurrence not-meeting the criteria was observed in 22 patients (group-B). group-A showed better 3-year recurrence-free survival rate than group-B (85.7% vs. 23.9%, P<0.05). Tumor size more than or equal to 6 cm was identified as the significant factor for having recurrence as in group-A pattern (P<0.05). Among the patients in group-A, re-recurrence after treating recurrent HCC was observed in eight patients (61.5%) with increased rate of extra-Milan criteria recurrence at 12 months from the initial recurrence. (II) After HR for HCCs meeting Milan criteria (n=39), recurrences within the criteria was observed in 15 patients (group-C) and recurrence not-meeting the criteria was observed in five patients (group-D). The 3-year recurrence-free survival rate was 62.8% in group-C and 40.0% in group-D (P<0.05). Increased rate of extra-Milan re-recurrence was observed later than 12 months from the recurrence in group-C. CONCLUSIONS: For HCCs not meeting Milan criteria, secondary LT after primary HR could be applied for a proportion of cases with less aggressiveness. For those meeting Milan criteria, primary LT should be the first therapeutic option. However, secondary LT could be offered for those with re-recurrence within criteria after primary HR.
机译:简介:即使在肝移植时代(LT),肝切除术(HR)通常也被用作肝细胞癌(HCC)的一线治疗。方法:参照米兰标准,对80例接受治愈性HCC的HCC患者的结局和详细的复发模式进行了检查。结果:(I)HCC超过米兰标准(n = 41)的HR后,在13例患者中观察到复发(A组),在22例患者中未达到标准的复发(B组)。 A组的3年无复发生存率优于B组(85.7%对23.9%,P <0.05)。肿瘤大小大于或等于6 cm被确定为复发的重要因素,如A组模式(P <0.05)。在A组患者中,有8例(61.5%)的HCC复发患者在复发后12个月内出现了超米兰标准复发率增加的复发。 (II)符合米兰标准的肝癌患者的HR(n = 39)后,在15例患者中观察到复发(C组),在5例患者中未见到复发复发(D组)。 C组3年无复发生存率62.8%,D组40.0%(P <0.05)。 C组复发后12个月后,观察到米兰外复发的发生率增加。结论:对于不符合米兰标准的肝癌,可以将原发性心律失常后的继发性LT应用于部分侵略性较低的病例。对于符合米兰标准的患者,主要的LT应该是首选治疗方法。但是,对于那些在原发性心力衰竭后再次复发且符合标准的患者,可以提供继发性LT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号